Influence of lipid composition of messenger RNA-loaded lipid nanoparticles on the protein expression via intratracheal administration in mice.

[1]  Elvin Blanco,et al.  Lipid nanoparticle-mediated mRNA delivery in lung fibrosis , 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  S. Kawakami,et al.  Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability , 2022, Pharmaceutics.

[3]  Hidefumi Mukai,et al.  Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: application of cyclic RGD peptide. , 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  Kristen D. Popowski,et al.  Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung , 2022, Extracellular Vesicle.

[5]  S. Kawakami,et al.  Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[6]  S. Kawakami,et al.  Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics , 2022, Drug metabolism and pharmacokinetics.

[7]  S. Kawakami,et al.  Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice , 2021, Pharmaceutics.

[8]  James E. Dahlman,et al.  Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs , 2021, Nature Biomedical Engineering.

[9]  R. Langer,et al.  Lipid nanoparticles for mRNA delivery , 2021, Nature Reviews Materials.

[10]  H. Sasaki,et al.  Anionic Complex with Efficient Expression and Good Safety Profile for mRNA Delivery , 2021, Pharmaceutics.

[11]  D. Knoell,et al.  Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Hairui Zhang,et al.  Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments , 2020, Pharmaceutics.

[13]  R. Williams,et al.  Inhaled nanoparticles-An updated review. , 2020, International journal of pharmaceutics.

[14]  T. Minko,et al.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[15]  P. Cullis,et al.  Lipid nanoparticle technology for therapeutic gene regulation in the liver , 2020, Advanced Drug Delivery Reviews.

[16]  S. Kawakami,et al.  Development of a DNA Vaccine for Melanoma Metastasis by Inhalation Based on an Analysis of Transgene Expression Characteristics of Naked pDNA and a Ternary Complex in Mouse Lung Tissues , 2020, Pharmaceutics.

[17]  M. Tokeshi,et al.  The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution. , 2020, Molecular pharmaceutics.

[18]  Dominik Witzigmann,et al.  On the role of helper lipids in lipid nanoparticle formulations of siRNA. , 2019, Nanoscale.

[19]  S. Hadrup,et al.  Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides. , 2019, Molecular pharmaceutics.

[20]  I. Sahu,et al.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  S. Kawakami,et al.  Ultrasound‐responsive nanobubble‐mediated gene transfection in the cerebroventricular region by intracerebroventricular administration in mice , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  S. Kawakami,et al.  Synthesis of a high functionality and quality lipid with gp130 binding hydrophobic peptide for the preparation of human glioma cell-targeted PEGylated liposomes , 2019, Journal of Drug Delivery Science and Technology.

[23]  I. Amit,et al.  Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting , 2018, Cell.

[24]  S. Kawakami,et al.  Efficient gene transfection to the brain with ultrasound irradiation in mice using stabilized bubble lipopolyplexes prepared by the surface charge regulation method , 2018, International journal of nanomedicine.

[25]  H. Harashima,et al.  In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration. , 2018, Molecular pharmaceutics.

[26]  P. Cullis,et al.  Lipid Nanoparticle Systems for Enabling Gene Therapies. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  P. Cullis,et al.  Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[28]  Gregg A. Duncan,et al.  The Mucus Barrier to Inhaled Gene Therapy. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  P. Cullis,et al.  Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[30]  N. Kaji,et al.  Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Robert J. Lee,et al.  The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. , 2016, Advanced drug delivery reviews.

[32]  D. Weissman,et al.  Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Daniel G. Anderson,et al.  Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. , 2015, Nano letters.

[34]  Judy Lieberman,et al.  Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown , 2015, Nature Biotechnology.

[35]  P. Cullis,et al.  Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[36]  B. MacVicar,et al.  Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain , 2013, Molecular therapy. Nucleic acids.

[37]  Akin Akinc,et al.  Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles , 2013, Molecular therapy. Nucleic acids.

[38]  Robert Langer,et al.  Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling , 2013, Nature Biotechnology.

[39]  H. Harashima,et al.  A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[40]  F. Liu,et al.  Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer. , 2012, Molecular pharmaceutics.

[41]  Nathan M Belliveau,et al.  Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA , 2012, Molecular therapy. Nucleic acids.

[42]  Shigeo Matsuda,et al.  Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** , 2012, Angewandte Chemie.

[43]  Wolfgang Kreyling,et al.  Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[44]  S. Kawakami,et al.  Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[45]  S. Kawakami,et al.  Enhanced Anti-Inflammation of Inhaled Dexamethasone Palmitate Using Mannosylated Liposomes in an Endotoxin-Induced Lung Inflammation Model , 2008, Molecular Pharmacology.

[46]  Fumiyoshi Yamashita,et al.  The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[47]  T. Flotte,et al.  Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.